Eckardt, J., Stasik, S., Kramer, M., Röllig, C., Krämer, A., Scholl, S., . . . Middeke, J. M. (2021). Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia. Cancers (Basel).
Stile di citazione ChicagoEckardt, Jan-Niklas, et al. "Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients With Acute Myeloid Leukemia." Cancers (Basel) 2021.
Citazione MLAEckardt, Jan-Niklas, et al. "Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients With Acute Myeloid Leukemia." Cancers (Basel) 2021.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.